337 related articles for article (PubMed ID: 28129947)
1. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Zhang YG; Wu S; Yi J; Xia Y; Jin D; Zhou J; Sun J
Clin Ther; 2017 Feb; 39(2):322-336. PubMed ID: 28129947
[TBL] [Abstract][Full Text] [Related]
2. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
4. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model.
Wu S; Yi J; Zhang YG; Zhou J; Sun J
Physiol Rep; 2015 Apr; 3(4):. PubMed ID: 25847918
[TBL] [Abstract][Full Text] [Related]
5. Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice.
Zhang Y; Xia Y; Sun J
Gut Microbes; 2024; 16(1):2363880. PubMed ID: 38860943
[TBL] [Abstract][Full Text] [Related]
6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
7. Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis.
Deitch JS; Alexander GM; Bensinger A; Yang S; Jiang JT; Heiman-Patterson TD
PLoS One; 2014; 9(6):e99879. PubMed ID: 24945277
[TBL] [Abstract][Full Text] [Related]
8. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
9. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice.
Figueroa-Romero C; Guo K; Murdock BJ; Paez-Colasante X; Bassis CM; Mikhail KA; Pawlowski KD; Evans MC; Taubman GF; McDermott AJ; O'Brien PD; Savelieff MG; Hur J; Feldman EL
Dis Model Mech; 2019 Nov; 13(2):. PubMed ID: 31597644
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
[TBL] [Abstract][Full Text] [Related]
11. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
12. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
[TBL] [Abstract][Full Text] [Related]
13. Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS.
Li X; Dong L; Li A; Yi J; Brotto M; Zhou J
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204833
[TBL] [Abstract][Full Text] [Related]
14. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
15. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
17. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.
Katsumata R; Ishigaki S; Katsuno M; Kawai K; Sone J; Huang Z; Adachi H; Tanaka F; Urano F; Sobue G
PLoS One; 2012; 7(9):e46185. PubMed ID: 23049975
[TBL] [Abstract][Full Text] [Related]
18. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.
Martin S; Battistini C; Sun J
Front Cell Infect Microbiol; 2022; 12():839526. PubMed ID: 35360111
[TBL] [Abstract][Full Text] [Related]
19. C-Boutons and Their Influence on Amyotrophic Lateral Sclerosis Disease Progression.
Wells TL; Myles JR; Akay T
J Neurosci; 2021 Sep; 41(38):8088-8101. PubMed ID: 34380764
[TBL] [Abstract][Full Text] [Related]
20. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H
Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
